Bremer Trust National Association’s Abiomed Inc ABMD Stock Holding History

Bremer Trust National Association’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$76K	Buy	+233	New	+$80.9K	0.02%	382

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bremer Trust National Association's ABMD Position: Q4 2018 in Review

Bremer Trust National Association opened a new position in Abiomed Inc (ABMD) in Q4 2018: 233 shares worth $76K. The stake represents 0.02% of the portfolio and ranks #382 among its holdings.

529 funds tracked by Wall St. Rank hold ABMD as of Q4 2018.

Bremer Trust National Association held 233 shares of Abiomed Inc worth $76K as of Q4 2018.
Abiomed Inc was a new Bremer Trust National Association position in Q4 2018.
Abiomed Inc made up 0.02% of Bremer Trust National Association's portfolio in Q4 2018, its #382 holding.
529 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2018.

Based on Bremer Trust National Association's 13F filing for Q4 2018, filed 11 Feb 2019.